Stay updated on Phase II Anti-PD1 Epigenetic Therapy Clinical Trial
Sign up to get notified when there's something new on the Phase II Anti-PD1 Epigenetic Therapy Clinical Trial page.

Latest updates to the Phase II Anti-PD1 Epigenetic Therapy Clinical Trial page
- Check2 days agoChange DetectedThe footer’s site revision number changes from v3.7.0 to v3.7.1 on the 403 error page.SummaryDifference0.2%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe study details page now displays a 403 Forbidden error, blocking access to the content.SummaryDifference0.5%

- Check23 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the study record details, indicating access to the record is blocked. The visible changes consist of the 403 message, header, and footer rather than the study content, signaling an access issue rather than an update to the study data.SummaryDifference21%

- Check44 days agoChange DetectedThe page footer now shows revision v3.6.6, replacing the previous v3.6.5 and signaling a recent update to the record.SummaryDifference0.0%

- Check65 days agoChange DetectedThe page's revision tag was updated to v3.6.5, indicating a newer version of the site template or content management update.SummaryDifference0.0%

- Check79 days agoChange DetectedThe site revision has been updated to v3.6.4, indicating a deployment update. No study data or page content is affected by this change.SummaryDifference0.0%

Stay in the know with updates to Phase II Anti-PD1 Epigenetic Therapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Phase II Anti-PD1 Epigenetic Therapy Clinical Trial page.